| GUARDANT HEALTH CL. A |
| USA |
| Gesundheit |
| US40131M1099 / A2N5RY |
| 5GH (Frankfurt) / GH (NASDAQ) |
| FRA:5GH, ETR:5GH, 5GH:GR, NASDAQ:GH |
| - |
| https://www.guardanthealt.. |
|
Guardant Health Inc. is a precision oncology company that develops blood- and tissue-based tests, data sets, and analytics to support cancer detection and treatment decisions. Its product portfolio includes liquid biopsy tests for tumor mutation prof..
>Volltext.. |
| 19041.91 Mio. EUR |
| 19605.66 Mio. EUR |
| 1021.09 Mio. EUR |
| -372.22 Mio. EUR |
| -391.34 Mio. EUR |
| -3.02 EUR |
| 1464.63 Mio. EUR |
| 909.21 Mio. EUR |
| -149.31 Mio. EUR |
| 3.11 |
| 47.23% |
| -13.02% |
| - |
| - |
| - |
| 5 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 21.587.980 Euro. |
| GUARDANT HEALTH |
| 06.09.26 |
|